MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.

Female Humans Uterine Cervical Neoplasms / diagnostic imaging Retrospective Studies Magnetic Resonance Imaging / methods Diffusion Magnetic Resonance Imaging / methods Prognosis
biomarkers magnetic resonance imaging prognostication radiomics uterine cervical neoplasms

Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
10 2023
Historique:
revised: 16 08 2023
received: 10 05 2023
accepted: 31 08 2023
medline: 17 11 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Accurate pretherapeutic prognostication is important for tailoring treatment in cervical cancer (CC). To investigate whether pretreatment MRI-based radiomic signatures predict disease-specific survival (DSS) in CC. Retrospective. CC patients (n = 133) allocated into training T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) at 1.5T or 3.0T. Radiomic features from segmented tumors were extracted from T2WI and DWI (high b-value DWI and apparent diffusion coefficient (ADC) maps). Radiomic signatures for prediction of DSS from T2WI (T2 The radiomic signatures T2 Radiomic signatures from T2WI and T2WI with DWI may provide added value for pretreatment risk assessment and for guiding tailored treatment strategies in CC.

Sections du résumé

BACKGROUND
Accurate pretherapeutic prognostication is important for tailoring treatment in cervical cancer (CC).
PURPOSE
To investigate whether pretreatment MRI-based radiomic signatures predict disease-specific survival (DSS) in CC.
STUDY TYPE
Retrospective.
POPULATION
CC patients (n = 133) allocated into training
FIELD STRENGTH/SEQUENCE
T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) at 1.5T or 3.0T.
ASSESSMENT
Radiomic features from segmented tumors were extracted from T2WI and DWI (high b-value DWI and apparent diffusion coefficient (ADC) maps).
STATISTICAL TESTS
Radiomic signatures for prediction of DSS from T2WI (T2
RESULTS
The radiomic signatures T2
DATA CONCLUSION
Radiomic signatures from T2WI and T2WI with DWI may provide added value for pretreatment risk assessment and for guiding tailored treatment strategies in CC.

Identifiants

DOI: 10.1002/cam4.6526 PMID: 37840437 PMC: PMC10652318
pubmed: 37840437
doi: 10.1002/cam4.6526
pmc: PMC10652318
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20251-20265

Informations de copyright

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

J Magn Reson Imaging. 2019 May;49(5):1420-1426
pubmed: 30362652
Front Oncol. 2021 Aug 16;11:706043
pubmed: 34485139
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Abdom Radiol (NY). 2022 Sep;47(9):2986-3002
pubmed: 34435228
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Obstet Gynecol. 2019 Jul;134(1):49-57
pubmed: 31188324
J Magn Reson Imaging. 2019 Jan;49(1):304-310
pubmed: 30102438
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Eur Radiol. 2020 Jun;30(6):3585-3593
pubmed: 32065284
Gynecol Oncol. 2019 Jan;152(1):87-93
pubmed: 30389105
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44
pubmed: 34669203
Eur Radiol. 2022 Apr;32(4):2540-2551
pubmed: 34642807
Cancer Imaging. 2022 Jul 16;22(1):35
pubmed: 35842679
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Radiother Oncol. 2019 Jun;135:107-114
pubmed: 31015155
Lancet. 2003 Jun 28;361(9376):2217-25
pubmed: 12842378
Eur J Radiol. 2016 Dec;85(12):2174-2181
pubmed: 27842663
Br J Cancer. 2011 Jan 18;104(2):361-8
pubmed: 21063398
Cancer Treat Rev. 2015 Jun;41(6):496-502
pubmed: 25892290
Front Oncol. 2020 Aug 20;10:1393
pubmed: 32974143
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Am J Obstet Gynecol. 2017 Oct;217(4):432.e1-432.e17
pubmed: 28599900
Eur Radiol. 2021 Oct;31(10):7802-7816
pubmed: 33852049
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Br J Radiol. 2022 Aug 1;95(1136):20211229
pubmed: 35604668
Br J Radiol. 2022 Jan 01;95(1129):20210838
pubmed: 34797703
Magn Reson Imaging. 2022 Oct;92:197-202
pubmed: 35842193
Eur J Radiol. 2019 May;114:128-135
pubmed: 31005162
Cancer Med. 2023 Oct;12(20):20251-20265
pubmed: 37840437
Insights Imaging. 2022 Jan 29;13(1):17
pubmed: 35092505
Eur Radiol. 2021 Dec;31(12):9361-9368
pubmed: 34003349
Eur Radiol. 2022 Sep;32(9):6444-6455
pubmed: 35332408
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645
Radiographics. 2021 Oct;41(6):1717-1732
pubmed: 34597235
Stat Med. 1997 Feb 28;16(4):385-95
pubmed: 9044528
Theranostics. 2020 Jan 16;10(5):2284-2292
pubmed: 32089742

Auteurs

Kari S Wagner-Larsen (KS)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Section for Radiology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
ORCID: 0000-0001-6309-0507

Erlend Hodneland (E)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Department of Mathematics, University of Bergen, Bergen, Norway.

Kristine E Fasmer (KE)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Section for Radiology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Njål Lura (N)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Section for Radiology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Kathrine Woie (K)

Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.

Bjørn I Bertelsen (BI)

Department of Pathology, Haukeland University Hospital, Bergen, Norway.

Øyvind Salvesen (Ø)

Clinical Research Unit, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Mari K Halle (MK)

Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.

Noeska Smit (N)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Department of Informatics, University of Bergen, Bergen, Norway.

Camilla Krakstad (C)

Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.

Ingfrid S Haldorsen (IS)

Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway.
Section for Radiology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › MRI-based radiomic signatures for pretreatment...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital féminin › Tumeurs de l'utérus › Tumeurs du col de l'utérus › MRI-based radiomic signatures for pretreatment...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › MRI-based radiomic signatures for pretreatment...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › MRI-based radiomic signatures for pretreatment...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Imagerie par résonance magnétique de diffusion › MRI-based radiomic signatures for pretreatment...
questionsmedicales.fr › Diagnostic › Pronostic › MRI-based radiomic signatures for pretreatment...